首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy
【24h】

Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy

机译:糖尿病肾病中总肾素白蛋白过滤和重吸收的增加

获取原文
           

摘要

The amount of albumin filtered through the glomeruli and reabsorbed at the proximal tubules in normal and in diabetic kidneys is debated. The megalin/cubilin complex mediates protein reabsorption, but genetic knockout of megalin is perinatally lethal. To overcome current technical problems, we generated a drug-inducible megalinxe2x80x93knockout mouse line, megalin(lox/lox);Ndrg1-CreERT2 (iMegKO), in which megalin expression can be shut off at any time by administration of tamoxifen (Tam). Tam administration in adult iMegKO mice decreased the expression of renal megalin protein by 92% compared with that in wildxe2x80x93type C57BL/6J mice and almost completely abrogated renal reabsorption of intravenously injected retinolxe2x80x93binding protein. Furthermore, urinary albumin excretion increased to 175 xcexbcg/d (0.46 mg albumin/mg creatinine) in Tam-treated iMegKO mice, suggesting that this was the amount of total nephron albumin filtration. By comparing Tam-treated, streptozotocin-induced diabetic iMegKO mice with Tam-treated nondiabetic iMegKO mice, we estimated that the development of diabetes led to a 1.9-fold increase in total nephron albumin filtration, a 1.8-fold increase in reabsorption, and a significant reduction in reabsorption efficiency (86% efficiency versus 96% efficiency in nondiabetic mice). Insulin treatment normalized these abnormalities. Akita;iMegKO mice, another model of type 1 diabetes, showed equivalent results. Finally, nondiabetic iMegKO mice had a glomerular sieving coefficient of albumin of 1.7xc3x9710xe2x88x925, which approximately doubled in diabetic iMegKO mice. This study reveals actual values and changes of albumin filtration and reabsorption in early diabetic nephropathy in mice, bringing new insights to our understanding of renal albumin dynamics associated with the hyperfiltration status of diabetic nephropathy.
机译:讨论了通过肾小球过滤并在正常肾脏和糖尿病肾脏的近端小管中重新吸收的白蛋白的量 n。 megalin / cubilin复合物介导蛋白质重吸收,但是megalin的基因敲除对围产期致死。 -CreERT2(iMegKO),可通过使用他莫昔芬(Tam)随时关闭巨蛋白表达。与野生型 xe2 x80 x93型C57BL / 6J小鼠相比,成年iMegKO小鼠的Tam给药使肾巨蛋白蛋白的表达降低了92% n,并且几乎完全消除了静脉注射视黄醇 xe2 x80 的肾脏重吸收。 x93结合蛋白。此外,在用Tam治疗的iMegKO小鼠中,尿白蛋白排泄增加至175 xce xbcg / d(0.46 mg白蛋白/ mg肌酐),表明这是肾单位白蛋白总过滤量。通过比较经Tam治疗的,链脲佐菌素诱导的糖尿病iMegKO小鼠与经过Tam治疗的非糖尿病iMegKO小鼠, n我们估计糖尿病的发展导致总肾素白蛋白过滤增加1.9倍,在肾脏中白蛋白过滤增加1.8倍 n重吸收,并显着降低了重吸收效率(非糖尿病小鼠的效率为86%,效率为96%)。胰岛素治疗使这些异常正常化。另一种1型糖尿病模型Akita; iMegKO小鼠显示出相同的结果。最后,非糖尿病iMegKO小鼠的肾小球筛查系数白蛋白为1.7 xc3 x9710 xe2 x88 x925,这在糖尿病iMegKO小鼠中约为两倍。这项研究揭示了小鼠早期糖尿病肾病中白蛋白滤过和重吸收的实际值和变化 n,为我们对与糖尿病肾病超滤状态相关的肾脏白蛋白动力学的理解提供了新见解。 n

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号